XML 19 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities    
Net loss $ (4,170) $ (1,705)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation 1 10
Stock-based compensation 164 412
Marketable equity securities revaluation (1,000) 194
Loss from extinguishment of convertible loans 878
Accrued interest on convertible loans 18
Amortization of premium related to convertible loans (1,087)
Loss from recognition of mandatorily redeemable Series B Preferred Stock 3,207
Change from revaluation of mandatorily redeemable Series B Preferred Stock 803
Change in:    
Other current assets 167 77
Accounts payable 239 5
Net cash used in operating activities (589) (1,198)
Cash flows from investing activities    
Purchase of property and equipment (1)
Proceeds from sale of marketable equity securities 5
Net cash provided by investing activities 4
Cash flows from financing activities    
License obligation (150) (150)
Net proceeds from issuance of mandatorily redeemable Series B Preferred Stock 100
Net cash used in financing activities (50) (150)
Decrease in cash, cash equivalents and restricted cash (635) (1,348)
Cash, cash equivalents and restricted cash at the beginning of the period 759 3,183
Cash, cash equivalents and restricted cash at the end of the period 124 1,835
Supplemental disclosure of non-cash financing activities:    
Common shares issued through receipt of marketable securities 765
Amount allocated to the repurchase right to existing right to future investment related to the 2016 Loan and the 2017 Loan (480)
Amount that was allocated to the right for future investment - the 2016 Loan 256
Amount that was allocated to the right for future investment - the 2017 Loan 386
Deemed dividend with respect to the repurchase of right for future investment 104
Amount allocated to the repurchase right to existing right to future investment related to the 2016  Loan and the 2017 Loan – May 2019 loan extension (153)
Amounts that were allocated to the right for future investment and warrants - the 2016 Loan – May 2019 loan extension 381
Amounts that were allocated to the right for future investment and warrants - loan 2017 – May 2019 loan extension 576
Deemed dividends with respect to the repurchase of right for future investment – May 2019 loan extension 81
Amount allocated to the 2016 Loan - March 2019 loan amendment 729
Amount allocated to the 2017 Loan - March 2019 loan amendment 1,037
Amount allocated to the 2016 Loan - May 2019 loan extension 634
Amount allocated to the 2017 Loan - May 2019 loan extension 922
Amounts transferred from Series B Preferred Stock investment to restricted deposit held in escrow 3,700
Investment in marketable securities (Bonus shares) 8,759
Recognition of contingent obligation with respect to future revenues 5,059
Issuance of mandatorily redeemable Series B Preferred Stock $ 7,400